Tyrian Diagnostics Limited (ASX:TDX) announced today that the company has completed the manufacture of an initial order of commercial ReadRite� alpha-amylase kits for Bayer CropScience AG, intended to be rolled-out in the North American market. The ReadRite test, which detects alpha-amylase in wheat, performed very well in an independent official evaluation which confirmed the test as a reliable measure for the determination of wheat quality.

This test, formerly referred to as WheatRite, is being marketed in Canada as the ReadRite alpha-amylase test for use with Tyrian�s Reader. The test provides grain industry stakeholders with a rapid, easy to use, and quantitative method for determining the quality of wheat at Point of Need.

�The results of the evaluation and the launch of the ReadRite product is a major accomplishment for Tyrian, and validates our DiagnostIQ� platform in the agriculture industry,� said Jenny Harry, PhD, Chief Executive Officer of Tyrian Diagnostics. �We have developed a strong working relationship with Bayer CropScience, and we look forward to continued collaboration on this and future products.�

Tyrian will continue to manufacture ReadRite� test kits in house, whilst concurrently establishing outsourced manufacturing of the kits to meet forecast sales increases in North America and other regions.

About ReadRite alpha-amylase test

The ReadRite� alpha-amylase test is a rapid wheat quality test that can be completed in five minutes and enables growers to make an on-farm assessment of the extent of rain damage to a crop in order to separate sound grain from damaged grain. The test is available as a rapid visual test that can be interpreted without instrumentation, or used in conjunction with the ReadRite� Reader to provide a more definitive quantitative result. Rain damage has a significant impact on the pricing of harvested wheat. Grading must be conducted by trading authorities prior to sale and/or export, but also may be performed at multiple points in the chain, from on-farm to wheat processor, to monitor and confirm grain quality.

About Tyrian�s DiagnostIQ Reader

Tyrian�s DiagnostIQ Reader is a proprietary device that utilizes optical detection technology combined with customized software to provide a quantitative measure of the level of diagnostic targets in samples processed in Tyrian�s point of need DiagnostIQ tests. The Reader can be configured to detect diagnostic targets in a wide range of sample types, and therefore has utility in the healthcare, agricultural, and veterinary fields.

About Tyrian Diagnostics

Tyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise in biomarker discovery and validation and diagnostic test development with a core focus on respiratory and infectious diseases. Tyrian�s product pipeline includes:

  • ReadRite� tests for crop quality management, which are partnered with Bayer CropScience; and
  • a rapid test for active tuberculosis, in collaboration with the US-based group Becton, Dickinson and Company.

In addition, Tyrian has many partnering opportunities in alternative fields, given its capabilities to work across the entire spectrum of diagnostic test development � from identification and isolation of biomarkers, point-of-need test design, clinical development or field testing to final product. Core technology of the company includes the DiagnostIQ test format, a handheld device that allows rapid and easy detection of protein markers associated with particular medical, veterinary or agricultural conditions.

Additional information about Tyrian Diagnostics can be found at www.tyriandx.com

Tyrian Diagnostics (ASX:TDX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tyrian Diagnostics Charts.
Tyrian Diagnostics (ASX:TDX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tyrian Diagnostics Charts.